Literature DB >> 24256665

The International Normalized Ratio overestimates coagulopathy in stable trauma and surgical patients.

Sean P McCully1, Loic J Fabricant, Nicholas R Kunio, Tahnee L Groat, Katherine M Watson, Jerome A Differding, Thomas G Deloughery, Martin A Schreiber.   

Abstract

BACKGROUND: The international normalized ratio (INR) was developed to assess adequacy of Coumadin dosing. Its use has been generalized to guide fresh frozen plasma (FFP) therapy in stable patients. Thrombelastography (TEG) is a whole-blood assay measuring the viscoelastic properties of the clot in near real time. This study hypothesized that INR does not reflect coagulopathy and should not be used to guide FFP therapy in stable trauma and surgical patients.
METHODS: Prospective observational data were collected from stable trauma and surgical patients (n = 106) who received FFP transfusions. Pretransfusion and posttransfusion blood samples were obtained to assess complete blood count, standard coagulation parameters (INR, partial thromboplastin time, fibrinogen and D-dimer), soluble clotting factors (II, V, VII, VIII, IX, X, XI, XII, proteins C and S) and TEG. Data were analyzed using a Mann-Whitney U-test. Significance was defined as p < 0.05.
RESULTS: A total of 262 U of FFP were transfused, with 78% of 106 patients receiving two or more units. Despite a reduction in INR, median TEG values remained within normal limits, while clotting factor levels retained adequate function to produce normal clotting before and following FFP transfusion.
CONCLUSION: The use of FFP in this population did not affect coagulation status in a clinically relevant manner based on TEG values and coagulation factor function. INR is not a predictor of coagulopathy and should not be used to guide coagulation factor replacement in stable trauma and surgical patients. LEVEL OF EVIDENCE: Diagnostic study, level III.

Entities:  

Mesh:

Year:  2013        PMID: 24256665     DOI: 10.1097/TA.0b013e3182a9676c

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  16 in total

1.  Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.

Authors:  Gregory R Stettler; Ernest E Moore; Hunter B Moore; Geoffrey R Nunns; Julia R Coleman; Arthur Colvis; Arsen Ghasabyan; Mitchell J Cohen; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-09       Impact factor: 3.313

Review 2.  Major bleeding after percutaneous image-guided biopsies: frequency, predictors, and periprocedural management.

Authors:  Sean A Kennedy; Lazar Milovanovic; Mehran Midia
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

3.  Trauma Resuscitation Consideration: Sex Matters.

Authors:  Julia R Coleman; Ernest E Moore; Jason M Samuels; Mitchell J Cohen; Angela Sauaia; Joshua J Sumislawski; Arsen Ghasabyan; James G Chandler; Anirban Banerjee; Christopher C Silliman; Erik D Peltz
Journal:  J Am Coll Surg       Date:  2019-01-21       Impact factor: 6.113

4.  Moderate elevations in international normalized ratio should not lead to delays in neurosurgical intervention in patients with traumatic brain injury.

Authors:  Susan E Rowell; Ronald R Barbosa; Tori C Lennox; Kelly A Fair; Abigail J Rao; Samantha J Underwood; Martin A Schreiber
Journal:  J Trauma Acute Care Surg       Date:  2014-12       Impact factor: 3.313

5.  All the bang without the bucks: Defining essential point-of-care testing for traumatic coagulopathy.

Authors:  Michael D Goodman; Amy T Makley; Dennis J Hanseman; Timothy A Pritts; Bryce R H Robinson
Journal:  J Trauma Acute Care Surg       Date:  2015-07       Impact factor: 3.313

Review 6.  Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis?

Authors:  Hunter B Moore; Robert D Winfield; Mayuki Aibiki; Matthew D Neal
Journal:  Shock       Date:  2017-08       Impact factor: 3.454

7.  The procoagulant molecule plasminogen activator inhibitor-1 is associated with injury severity and shock in patients with and without traumatic brain injury.

Authors:  Mary Condron; Susan Rowell; Elizabeth Dewey; Taylor Anderson; Lelani Lealiiee; David Farrell; Holly Hinson
Journal:  J Trauma Acute Care Surg       Date:  2018-11       Impact factor: 3.313

Review 8.  Trauma-induced coagulopathy.

Authors:  Ernest E Moore; Hunter B Moore; Lucy Z Kornblith; Matthew D Neal; Maureane Hoffman; Nicola J Mutch; Herbert Schöchl; Beverley J Hunt; Angela Sauaia
Journal:  Nat Rev Dis Primers       Date:  2021-04-29       Impact factor: 65.038

Review 9.  Monitoring of hematological and hemostatic parameters in neurocritical care patients.

Authors:  Andrew M Naidech; Monisha A Kumar
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

10.  Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis.

Authors:  Y C Lau; Q Xiong; P Ranjit; G Y H Lip; A D Blann
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.